Michigan-OPEN Leadership

Surgeons have few guidelines to direct postoperative prescribing, and they frequently overprescribe narcotics because they are not sure how much patients will need following surgery. The Michigan-OPEN program hopes to inform post-operative prescribing so that prescribers are giving enough medication to allow patients to recover without leaving extra pills in their cabinets. Through a partnership with Michigan’s robust network of Continuous Quality Improvement programs funded by Blue Cross Blue Shield of Michigan, michigan-open has a unique platform to gather data and implement change on a statewide scale to transform surgical pain management and curb opioid misuse. 

In special partnership with: 

UMHS Division of Pain Research 

UMHS Department of Surgery 

UMHS Department of Anesthesiology 

U-M Center for Healthcare Outcomes & Policy 

U-M Institute for Healthcare Policy & Innovation 

Chad Brummett, M.D.

Associate Professor, Department of Anesthesiology
Director, Division of Pain Research, Department of Anesthesiology

Dr. Brummett is the director of the Division of Pain Research and, more broadly, is the Director of Clinical Research in the Department of Anesthesiology. His research interests include predictors of acute and chronic post-surgical pain and failure to derive benefit for interventions and surgeries done primarily for pain. He also studies chronic opioid use in the perioperative period to help quantify the scope of the problem and patient characteristics associated with chronic opioid use, and is working on developing interventions to aid patients in weaning. 

Michael Englesbe, M.D.

Professor, Section of Transplantation Surgery, Department of Surgery

Dr. Englesbe, is associate professor of surgery in the Section of Transplantation Surgery. His research is concerned with the relationship between the costs and quality of surgical care, and also specifically focuses on patient frailty, morphomics (the analysis of human body factors derived from medical imaging to understand how variations impact and predict patient risk and outcomes), and surgical outcomes and post-operative opioid utilization. He is also the associate director of the Michigan Surgical Quality Collaborative (MSQC), directs the Michigan Surgical Home and Optimization Program (MSHOP - a CMS-CMMI funded initiative), and co-directs the Michigan Opioid Prescribing and Engagement Network (M-OPEN).  

Jennifer F. Waljee, M.D., M.P.H, M.S.

Associate Professor, Plastic Surgery, Department of Surgery

Dr. Waljee serves as an assistant professor in the Section of Plastic and Reconstructive Surgery at the University of Michigan School of Medicine. Some of her research examines the variation in PROs across hospitals and surgeons, and the patient-, surgeon-, and hospital-level factors that drive this variation at the population level for four surgical conditions: bariatric, urologic, wrist, and spine surgery; the extent to which PROs are independent measures of quality compared with clinical outcomes; and the ways in which patients might use PROs in conjunction with clinical outcomes as measures of hospital and surgeon performance.